Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a
Nu se va prescrie în regim compensat pentru tratamentul litiazei biliare
Yüklə 4,39 Mb.
|
| Nu se va prescrie în regim compensat pentru tratamentul litiazei biliare
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului. ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ A05AA02 ACIDUM CAPS. 250 mg URSODEOXYCHOLICUM URSOFALK(R) 250 mg DR. FALK PHARMA GMBH URSOSAN 250 mg PRO. MED. CS PRAHA AS ________________________________________________________________________________ ______________________________________________________________________________ | 959 |A11CC03| ALFACALCIDOLUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ A11CC03 ALFACALCIDOLUM CAPS. MOI 0.25 µg ALPHA D3 0,25 µg 0.25 µg TEVA PHARMACEUTICALS SRL
ALPHA D3 0.50 µg 0.50 µg TEVA PHARMACEUTICALS SRL ________________________________________________________________________________
| 960 |B01AB05| ENOXAPARINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ B01AB05 ENOXAPARINUM SOL. INJ. 2000 ui anti-Xa/0.2 ml CLEXANE 2000 ui 2000 ui anti-Xa/0.2 ml LAB. AVENTIS anti-Xa/0.2 ml
anti-Xa/0,4 ml CLEXANE 4000 ui 4000 ui anti-Xa/0,4 ml LAB. AVENTIS anti-Xa/0.4 ml B01AB05 ENOXAPARINUM SOL. INJ. 6000 ui anti-Xa/0.6 ml CLEXANE 6000 ui 6000 ui anti-Xa/0.6 ml LAB. AVENTIS anti-Xa/0.6 ml B01AB05 ENOXAPARINUM SOL. INJ. 8000 ui anti-Xa/0.8 ml CLEXANE 8000 ui 8000 ui anti-Xa/0.8 ml LAB. AVENTIS anti-Xa/0.8 ml B01AB05 ENOXAPARINUM SOL. INJ. 2000 ui anti-Xa/0.2 ml CLEXANE 2000 ui 2000 ui anti-Xa/0.2 ml LAB. AVENTIS anti-Xa/0.2 ml B01AB05 ENOXAPARINUM SOL. INJ. 4000 ui anti-Xa/0,4 ml CLEXANE 4000 ui 4000 ui anti-Xa/0,4 ml LAB. AVENTIS anti-Xa/0.4 ml B01AB05 ENOXAPARINUM SOL. INJ. 6000 ui anti-Xa/0.6 ml CLEXANE 6000 ui 6000 ui anti-Xa/0.6 ml LAB. AVENTIS anti-Xa/0.6 ml ________________________________________________________________________________
| 961 |B01AB04| DALTEPARINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ B01AB04 DALTEPARINUM SOL. INJ. 10000 ui/ml FRAGMIN 10000 UI/ml 10000 ui/ml PFIZER EUROPE MA EEIG
FRAGMIN 15000 UI/0,6 ml 15000 ui/0.6 ml PFIZER EUROPE MA EEIG B01AB04 DALTEPARINUM SOL. INJ. 2500 ui/0.2 ml FRAGMIN 2500 UI/0,2 ml 2500 ui/0.2 ml PFIZER EUROPE MA EEIG B01AB04 DALTEPARINUM SOL. INJ. 5000 ui/0.2 ml FRAGMIN 5000 UI/0,2 ml 5000 ui/0.2 ml PFIZER EUROPE MA EEIG B01AB04 DALTEPARINUM SOL. INJ. 7500 ui/0.3 ml FRAGMIN 7500 UI/0,3 ml 7500 ui/0.3 ml PFIZER EUROPE MA EEIG ________________________________________________________________________________
| 962 |B01AB08| REVIPARINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ B01AB08 REVIPARINUM SOL. INJ. 1432 ui/0.25 ml CLIVARIN(R) 1432 UI/0,25 ml 1432 ui/0.25 ml ABBOTT GMBH & CO. KG
CLIVARIN(R) 3436 UI/0,6 ml 3436 ui/0.6 ml ABBOTT GMBH & CO. KG ________________________________________________________________________________
Yüklə 4,39 Mb. Dostları ilə paylaş:
|